Mackenzie Financial
ADPT icon

Mackenzie Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Mackenzie Financial’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,230
Closed -$83K – 1428
2022
Q2 		$83K Buy
+10,230
New +$89.9K ﹤0.01% 1356

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial's ADPT Position: Q3 2022 in Review

Mackenzie Financial sold out of Adaptive Biotechnologies (ADPT) in Q3 2022, closing a stake of 10,230 shares — an estimated $83K sold.

Mackenzie Financial first reported a position in ADPT in Q2 2022 and held it in 1 quarter. The position peaked at $83K in Q2 2022. 226 funds tracked by Wall St. Rank hold ADPT as of Q3 2022.

  • Mackenzie Financial reported no remaining Adaptive Biotechnologies position as of Q3 2022 after selling out during the quarter.
  • Mackenzie Financial sold 10,230 Adaptive Biotechnologies shares in Q3 2022, an estimated $83K.
  • Mackenzie Financial first reported a position in Adaptive Biotechnologies in Q2 2022 and held it in 1 quarter.
  • Mackenzie Financial's Adaptive Biotechnologies position peaked at $83K in Q2 2022.
  • 226 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2022.

Based on Mackenzie Financial's 13F filing for Q3 2022, filed 7 Oct 2022.